478 related articles for article (PubMed ID: 15039815)
21. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
[TBL] [Abstract][Full Text] [Related]
22. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
23. [Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension].
Agabiti-Rosei E; Giovannini E; Mancia G; Novo S; Pede S; Rappelli A; Sau F; Trevi G; Verdecchia P
Cardiologia; 1999 Mar; 44(3):299-312. PubMed ID: 10327733
[No Abstract] [Full Text] [Related]
24. Evaluation of cardiac damage in hypertension.
Motz W; Scheler S; Schwartzkopff B; Strauer BE
J Cardiovasc Risk; 1995 Feb; 2(1):16-26. PubMed ID: 7606635
[TBL] [Abstract][Full Text] [Related]
25. Preventing congestive heart failure.
Cohn JN
Am Fam Physician; 1998 Apr; 57(8):1901-4. PubMed ID: 9575327
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
Agabiti-Rosei E; Muiesan ML; Salvetti M
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
[TBL] [Abstract][Full Text] [Related]
27. [So-called uremic heart diseases].
Grollier G; Hurault de Ligny B; Bonnet H; Scanu P; Potier JC
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):401-6. PubMed ID: 2108635
[TBL] [Abstract][Full Text] [Related]
28. Influence of multiple risk factors on the hazard of hypertension.
Kannel WB
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137
[TBL] [Abstract][Full Text] [Related]
29. From hypertension to heart failure: what have we learned?
Wilson PW
Clin Cardiol; 1999 Oct; 22 Suppl 5():V1-10. PubMed ID: 10526697
[TBL] [Abstract][Full Text] [Related]
30. The what, why and how of hypertensive heart disease.
Weber KT
J Hum Hypertens; 1994 Sep; 8(9):665-75. PubMed ID: 7807496
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
[TBL] [Abstract][Full Text] [Related]
32. [Hypertensive microvascular disease].
Schannwell CM; Steiner S; Strauer BE
Herz; 2005 Feb; 30(1):26-36. PubMed ID: 15754153
[TBL] [Abstract][Full Text] [Related]
33. Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression.
Ruel M; Al-Faleh H; Kulik A; Chan KL; Mesana TG; Burwash IG
J Thorac Cardiovasc Surg; 2006 May; 131(5):1036-44. PubMed ID: 16678587
[TBL] [Abstract][Full Text] [Related]
34. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.
Das SR; Drazner MH; Yancy CW; Stevenson LW; Gersh BJ; Dries DL
Am Heart J; 2004 Nov; 148(5):883-8. PubMed ID: 15523322
[TBL] [Abstract][Full Text] [Related]
35. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
36. Essentials of the diagnosis of heart failure.
Shamsham F; Mitchell J
Am Fam Physician; 2000 Mar; 61(5):1319-28. PubMed ID: 10735340
[TBL] [Abstract][Full Text] [Related]
37. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of prolonged ventricular repolarization in hypertension.
Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
[TBL] [Abstract][Full Text] [Related]
39. [Arterial hypertension: clinical significance of U wave inversion in electrocardiogram].
Caruso G; Trovato GM; Todaro G; Spatola S
Medicina (Firenze); 1990; 10(2):161-3. PubMed ID: 2148793
[TBL] [Abstract][Full Text] [Related]
40. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
Lip GY; Felmeden DC; Li-Saw-Hee FL; Beevers DG
Eur Heart J; 2000 Oct; 21(20):1653-65. PubMed ID: 11032692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
